7
  icon-folder.gif   Conference Reports for NATAP  
 
  DDW - Digestive Disease Week 2014
May 25, 2016
San Diego, CA
Back grey_arrow_rt.gif
 
 
 
Sofosbuvir/Velpatasvir for 12 Weeks Results in High SVR12 Rates in Patients With Negative Predictors of Response to Treatment: an Integrated Analysis of Efficacy From the ASTRAL-1, ASTRAL-2, and ASTRAL-3 Studies
 
 
  Reported by Jules Levin
DDW May 22-24 San Diego, CA

DDW1

Nancy Reau1, Kosh Agarwal2, Keyur Patel3, Didier Samuel4, Marc Bourliere5, Ziad H. Younes6, Timothy R. Morgan7, Simone Strasser8,
Barbara Leggett9, Lin Liu10, Xiao Ding10, John McNally10, Anu Osinusi10, Bradley Collins10, Sarjita Naik10, Macky Natha10, Diana Brainard10, John McHutchison10, Nezam Afdhal11
1Rush University Medical Center, Chicago, IL, USA; 2Institute of Liver Studies, Kings College Hospital, London, UK; 3University Health Network Liver Clinic, Toronto, Canada; 4Centre Hepato-Biliaire, Villejuif, France; 5H˘pital Saint Joseph, Marseille, France; 6GastroOne, Germantown, TN, USA; 7VA Long Beach, Long Beach, CA, USA; 8Royal Prince Alfred Hospital, Camperdown, NSW, Australia; 9Royal Brisbane and Women's Hospital, Brisbane, Australia; 10Gilead Sciences, Inc., Foster City, California, USA; 11Beth Israel Deaconess Medical Center, Boston, USA
 
Su1413

DDW2

DDW3

DDW4

DDW5

DDW6

DDW7

DDW8

DDW9

DDW10